The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results

The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results Publisher

Ostovar A^{1, 2} ; Sepanlou S³ ; Shariati M⁴ ; Mahdavi Hezaveh A² ; Yousefi E² ; Hodjatzadeh A² ; Afkar M² ; Pariani A² ; Moghisi A² ; Khalagi K^{1, 5} ; Najmi M² ; Bashti S² ; Aghamohammadi S⁶ ; Bagherzade Yazdi M⁷ Show All Authors

Ostovar A^{1, 2}
Sepanlou S³
Shariati M⁴
Mahdavi Hezaveh A²
Yousefi E²
Hodjatzadeh A²
Afkar M²
Pariani A²
Moghisi A²
Khalagi K^{1, 5}
Najmi M²
Bashti S²
Aghamohammadi S⁶
Bagherzade Yazdi M⁷
Atefi A⁸
Joneidi A⁹
Barakati H¹⁰
Heshmat R¹¹
Peykari N¹²
Ranjbar M¹³
Hammelman C¹³
Mendis S¹⁴
Pariyanzeitooni M¹⁵
Mohammadi N¹⁵
Noemani K¹⁶
Barati H¹⁷
Alborzinia R¹⁷
Mirshfiee P¹⁸
Khaligh N¹⁹
Anvari M²⁰
Morsali A²⁰
Shirzadian A²¹
Hasani M²²
Zakeri M²³
Alizadeh Barzian K²⁴
Azadmehr H²⁵
Ghasemi A²⁵
Delshad A²⁶
Hajiuni R²⁷
Shafieinia MA²⁸
Dolatabad M²⁹
Soltani M²⁹
Azizi A³⁰
Izadi M³¹
Rokhshad H³²
Sadeghi G³²
Rahmani MH³³
Sedaghat SM³⁴
Sadeghzade H³⁴
Mirmoieni R³⁵
Golmohammadi A³⁶
Najafi Moghadam T³⁶
Ehsanzadeh A³⁷
Parvin A³⁸
Ahmadian M³⁹
Hosseinkhani R³⁹
Shadmand S⁴⁰
Shahrokhi F⁴¹
Panje Shahi M⁴²
Shafiei Bafti M⁴³
Shahabadi S⁴⁴
Shaddel S⁴⁵
Bayat Asghari A⁴⁶
Talebi E⁴⁷
Sharafi S⁴⁸
Kooshki M⁴⁹
Asadiyan F⁵⁰
Sadeghi MJ⁵¹
Eghbali B⁵¹
Norouzinezhad G⁵²
Farrokhzad S^{53, 54}
Mirheidari M⁵⁵
Nejadghaderi M⁵⁶
Iran Nezhad N⁵⁶
Mehri SM⁵⁷
Rahimzadeh A⁵⁸
Etminanbakhsh H⁵⁹
Dalili A⁶⁰
Aminforghani H⁶¹
Rahbar MN⁶²
Rostampour S⁶³
Fateh M^{64, 65}
Moradi F⁶⁶
Mousavi SA⁶⁷
Pourabazari G⁶⁸
Sharbafi J⁶⁹
Aminmanesh A⁷⁰
Karimi A⁷¹
Sarbazi M⁷¹
Farbakhsh F⁷¹
Alinezhad J⁷²
Parishan Kordiani T⁷³
Dalili N⁷⁴
Parisay Z⁷⁵
Sadeghian MR⁷⁶
Bazishad A⁷⁷
Sartipi M^{78, 79}
Seydi A⁸⁰
Raeisi A⁸¹

Source: Journal of Diabetes and Metabolic Disorders Published:2023

Abstract

Purpose: Hypertension is one of the most important risk factors for premature mortality and morbidity in Iran. The objective of the Iranian blood pressure (BP) measurement campaign was to identify individuals with raised blood pressure and providing appropriate care and increase the awareness among the public and policymakers of the importance of tackling hypertension. Methods: The campaign was conducted in two phases. The first (communication) phase started on May 17th (International Hypertension Day). The second phase started on June 8th, 2019, and lasted up to July 7th during which, blood pressures were measured. The target population was Iranians aged ≥ 30 years. Participants voluntarily referred to health houses in rural and health posts and comprehensive health centers in urban areas in the setting of the Primary Health Care network. Additionally, over 13,700 temporary stations were set up in highly visited places in urban areas. Volunteer healthcare staff interviewed the participants, measured their BP, and provided them with lifestyle advice and knowledge of the risks and consequences of high blood pressure. They referred participants to physicians in case their BP was high. Participants immediately received a text message containing the relevant advice based on their measured BP and their past history. Results: Blood pressure was measured for a total of 26,678,394 participants in the campaign. A total of 13,722,148 participants (51.4%) were female. The mean age was 46 ± 14.1 years. Among total participants, 15,012,693 adults (56.3%) with no past history of hypertension had normal BP, 7,959,288 participants had BP in the prehypertension range (29.8%), and finally, 3,706,413 participants (13.9%) had either past medical history of hypertension, used medications, or had high BP measured in the campaign. Conclusion: The campaign was feasible with the objective to increase the awareness among the public and policymakers of the importance of tackling hypertension in Iran. © 2022, The Author(s), under exclusive licence to Tehran University of Medical Sciences.

Related Docs

View other Related Docs

1. Long-Term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: A Systematic Review and Meta-Analysis of 178 Population-Based Studies, Current Hypertension Reports (2021)

2. Population Attributable Fraction Estimates of Cardiovascular Diseases in Different Blood Pressure Levels in a Large-Scale Cross-Sectional Study: A Focus on Prevention Strategies and Treatment Coverage, Blood Pressure Monitoring (2023)

3. Prevalence, Awareness, Treatment, and Control of Hypertension Among Adult Residents of Tehran: The Tehran Cohort Study, Global Heart (2022)

Experts (# of related papers)

View all Related Experts

Farshad Farzadfar (8)

Reza Malekzadeh (6)

Style	Citing Format
MLA	Ostovar A, et al.. "The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results." Journal of Diabetes and Metabolic Disorders, vol. 22, no. 1, 2023, pp. 899-911.
APA	Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, Afkar M, Pariani A, Moghisi A, Khalagi K, Najmi M, Bashti S, Aghamohammadi S, Bagherzade Yazdi M, Atefi A, Joneidi A, Barakati H, Heshmat R, Peykari N, ... Raeisi A (2023). The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results. Journal of Diabetes and Metabolic Disorders, 22(1), 899-911.
Chicago	Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, Afkar M, et al.. "The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results." Journal of Diabetes and Metabolic Disorders 22, no. 1 (2023): 899-911.
Harvard	Ostovar A et al. (2023) 'The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results', Journal of Diabetes and Metabolic Disorders, 22(1), pp. 899-911.
Vancouver	Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, et al.. The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results. Journal of Diabetes and Metabolic Disorders. 2023;22(1):899-911.
BibTex	@article{ author = {Ostovar A and Sepanlou S and Shariati M and Mahdavi Hezaveh A and Yousefi E and Hodjatzadeh A and Afkar M and Pariani A and Moghisi A and Khalagi K and Najmi M and Bashti S and Aghamohammadi S and Bagherzade Yazdi M and Atefi A and Joneidi A and Barakati H and Heshmat R and Peykari N and Ranjbar M and Hammelman C and Mendis S and Pariyanzeitooni M and Mohammadi N and Noemani K and Barati H and Alborzinia R and Mirshfiee P and Khaligh N and Anvari M and Morsali A and Shirzadian A and Hasani M and Zakeri M and Alizadeh Barzian K and Azadmehr H and Ghasemi A and Delshad A and Hajiuni R and Shafieinia MA and Dolatabad M and Soltani M and Azizi A and Izadi M and Rokhshad H and Sadeghi G and Rahmani MH and Sedaghat SM and Sadeghzade H and Mirmoieni R and Golmohammadi A and Najafi Moghadam T and Ehsanzadeh A and Parvin A and Ahmadian M and Hosseinkhani R and Shadmand S and Shahrokhi F and Panje Shahi M and Shafiei Bafti M and Shahabadi S and Shaddel S and Bayat Asghari A and Talebi E and Sharafi S and Kooshki M and Asadiyan F and Sadeghi MJ and Eghbali B and Norouzinezhad G and Farrokhzad S and Mirheidari M and Nejadghaderi M and Iran Nezhad N and Mehri SM and Rahimzadeh A and Etminanbakhsh H and Dalili A and Aminforghani H and Rahbar MN and Rostampour S and Fateh M and Moradi F and Mousavi SA and Pourabazari G and Sharbafi J and Aminmanesh A and Karimi A and Sarbazi M and Farbakhsh F and Alinezhad J and Parishan Kordiani T and Dalili N and Parisay Z and Sadeghian MR and Bazishad A and Sartipi M and Seydi A and Raeisi A}, title = {The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {22}, number = {1}, pages = {899-911}, year = {2023} }
RIS	TY - JOUR AU - Ostovar A AU - Sepanlou S AU - Shariati M AU - Mahdavi Hezaveh A AU - Yousefi E AU - Hodjatzadeh A AU - Afkar M AU - Pariani A AU - Moghisi A AU - Khalagi K AU - Najmi M AU - Bashti S AU - Aghamohammadi S AU - Bagherzade Yazdi M AU - Atefi A AU - Joneidi A AU - Barakati H AU - Heshmat R AU - Peykari N AU - Ranjbar M AU - Hammelman C AU - Mendis S AU - Pariyanzeitooni M AU - Mohammadi N AU - Noemani K AU - Barati H AU - Alborzinia R AU - Mirshfiee P AU - Khaligh N AU - Anvari M AU - Morsali A AU - Shirzadian A AU - Hasani M AU - Zakeri M AU - Alizadeh Barzian K AU - Azadmehr H AU - Ghasemi A AU - Delshad A AU - Hajiuni R AU - Shafieinia MA AU - Dolatabad M AU - Soltani M AU - Azizi A AU - Izadi M AU - Rokhshad H AU - Sadeghi G AU - Rahmani MH AU - Sedaghat SM AU - Sadeghzade H AU - Mirmoieni R AU - Golmohammadi A AU - Najafi Moghadam T AU - Ehsanzadeh A AU - Parvin A AU - Ahmadian M AU - Hosseinkhani R AU - Shadmand S AU - Shahrokhi F AU - Panje Shahi M AU - Shafiei Bafti M AU - Shahabadi S AU - Shaddel S AU - Bayat Asghari A AU - Talebi E AU - Sharafi S AU - Kooshki M AU - Asadiyan F AU - Sadeghi MJ AU - Eghbali B AU - Norouzinezhad G AU - Farrokhzad S AU - Mirheidari M AU - Nejadghaderi M AU - Iran Nezhad N AU - Mehri SM AU - Rahimzadeh A AU - Etminanbakhsh H AU - Dalili A AU - Aminforghani H AU - Rahbar MN AU - Rostampour S AU - Fateh M AU - Moradi F AU - Mousavi SA AU - Pourabazari G AU - Sharbafi J AU - Aminmanesh A AU - Karimi A AU - Sarbazi M AU - Farbakhsh F AU - Alinezhad J AU - Parishan Kordiani T AU - Dalili N AU - Parisay Z AU - Sadeghian MR AU - Bazishad A AU - Sartipi M AU - Seydi A AU - Raeisi A TI - The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results JO - Journal of Diabetes and Metabolic Disorders VL - 22 IS - 1 SP - 899 EP - 911 PY - 2023 ER -

Style

Citing Format

MLA

Ostovar A, et al.. "The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results." Journal of Diabetes and Metabolic Disorders, vol. 22, no. 1, 2023, pp. 899-911.

APA

Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, Afkar M, Pariani A, Moghisi A, Khalagi K, Najmi M, Bashti S, Aghamohammadi S, Bagherzade Yazdi M, Atefi A, Joneidi A, Barakati H, Heshmat R, Peykari N, ... Raeisi A (2023). The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results. Journal of Diabetes and Metabolic Disorders, 22(1), 899-911.

Chicago

Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, Afkar M, et al.. "The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results." Journal of Diabetes and Metabolic Disorders 22, no. 1 (2023): 899-911.

Harvard

Ostovar A et al. (2023) 'The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results', Journal of Diabetes and Metabolic Disorders, 22(1), pp. 899-911.

Vancouver

Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, et al.. The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results. Journal of Diabetes and Metabolic Disorders. 2023;22(1):899-911.

BibTex

@article{ author = {Ostovar A and Sepanlou S and Shariati M and Mahdavi Hezaveh A and Yousefi E and Hodjatzadeh A and Afkar M and Pariani A and Moghisi A and Khalagi K and Najmi M and Bashti S and Aghamohammadi S and Bagherzade Yazdi M and Atefi A and Joneidi A and Barakati H and Heshmat R and Peykari N and Ranjbar M and Hammelman C and Mendis S and Pariyanzeitooni M and Mohammadi N and Noemani K and Barati H and Alborzinia R and Mirshfiee P and Khaligh N and Anvari M and Morsali A and Shirzadian A and Hasani M and Zakeri M and Alizadeh Barzian K and Azadmehr H and Ghasemi A and Delshad A and Hajiuni R and Shafieinia MA and Dolatabad M and Soltani M and Azizi A and Izadi M and Rokhshad H and Sadeghi G and Rahmani MH and Sedaghat SM and Sadeghzade H and Mirmoieni R and Golmohammadi A and Najafi Moghadam T and Ehsanzadeh A and Parvin A and Ahmadian M and Hosseinkhani R and Shadmand S and Shahrokhi F and Panje Shahi M and Shafiei Bafti M and Shahabadi S and Shaddel S and Bayat Asghari A and Talebi E and Sharafi S and Kooshki M and Asadiyan F and Sadeghi MJ and Eghbali B and Norouzinezhad G and Farrokhzad S and Mirheidari M and Nejadghaderi M and Iran Nezhad N and Mehri SM and Rahimzadeh A and Etminanbakhsh H and Dalili A and Aminforghani H and Rahbar MN and Rostampour S and Fateh M and Moradi F and Mousavi SA and Pourabazari G and Sharbafi J and Aminmanesh A and Karimi A and Sarbazi M and Farbakhsh F and Alinezhad J and Parishan Kordiani T and Dalili N and Parisay Z and Sadeghian MR and Bazishad A and Sartipi M and Seydi A and Raeisi A}, title = {The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {22}, number = {1}, pages = {899-911}, year = {2023} }

RIS

TY - JOUR
AU - Ostovar A
AU - Sepanlou S
AU - Shariati M
AU - Mahdavi Hezaveh A
AU - Yousefi E
AU - Hodjatzadeh A
AU - Afkar M
AU - Pariani A
AU - Moghisi A
AU - Khalagi K
AU - Najmi M
AU - Bashti S
AU - Aghamohammadi S
AU - Bagherzade Yazdi M
AU - Atefi A
AU - Joneidi A
AU - Barakati H
AU - Heshmat R
AU - Peykari N
AU - Ranjbar M
AU - Hammelman C
AU - Mendis S
AU - Pariyanzeitooni M
AU - Mohammadi N
AU - Noemani K
AU - Barati H
AU - Alborzinia R
AU - Mirshfiee P
AU - Khaligh N
AU - Anvari M
AU - Morsali A
AU - Shirzadian A
AU - Hasani M
AU - Zakeri M
AU - Alizadeh Barzian K
AU - Azadmehr H
AU - Ghasemi A
AU - Delshad A
AU - Hajiuni R
AU - Shafieinia MA
AU - Dolatabad M
AU - Soltani M
AU - Azizi A
AU - Izadi M
AU - Rokhshad H
AU - Sadeghi G
AU - Rahmani MH
AU - Sedaghat SM
AU - Sadeghzade H
AU - Mirmoieni R
AU - Golmohammadi A
AU - Najafi Moghadam T
AU - Ehsanzadeh A
AU - Parvin A
AU - Ahmadian M
AU - Hosseinkhani R
AU - Shadmand S
AU - Shahrokhi F
AU - Panje Shahi M
AU - Shafiei Bafti M
AU - Shahabadi S
AU - Shaddel S
AU - Bayat Asghari A
AU - Talebi E
AU - Sharafi S
AU - Kooshki M
AU - Asadiyan F
AU - Sadeghi MJ
AU - Eghbali B
AU - Norouzinezhad G
AU - Farrokhzad S
AU - Mirheidari M
AU - Nejadghaderi M
AU - Iran Nezhad N
AU - Mehri SM
AU - Rahimzadeh A
AU - Etminanbakhsh H
AU - Dalili A
AU - Aminforghani H
AU - Rahbar MN
AU - Rostampour S
AU - Fateh M
AU - Moradi F
AU - Mousavi SA
AU - Pourabazari G
AU - Sharbafi J
AU - Aminmanesh A
AU - Karimi A
AU - Sarbazi M
AU - Farbakhsh F
AU - Alinezhad J
AU - Parishan Kordiani T
AU - Dalili N
AU - Parisay Z
AU - Sadeghian MR
AU - Bazishad A
AU - Sartipi M
AU - Seydi A
AU - Raeisi A
TI - The Iranian Blood Pressure Measurement Campaign, 2019: Study Protocol and Preliminary Results
JO - Journal of Diabetes and Metabolic Disorders
VL - 22
IS - 1
SP - 899
EP - 911
PY - 2023
ER -

Science Communicator Platform

Authors

Abstract